Colgate-Palmolive Company (CL) earnings on May 1, 2026

Before the market opens Q1 2026

More Colgate-Palmolive Company earnings

Prior outlook: Pessimistic Outcome: Missed

CL's stock price performed very well after its earnings announcement, closing significantly higher. This strong move occurred despite a negative outlook beforehand.

CL price around the earnings

87.28

Change: +2.2%

2026-05-01, 19:59 UTC

Start of the measured window
84.72 86.24 87.77 89.29 85.39
Price series around the eventClosing price per minute from before the event to the end of the measured window.
May 1, 2026
  • Price: green if it ends above the starting price; red if it ends below
  • Start of the measured window
  • Market open
  • Starting price
Price series around the event

Prior thesis

Prior outlook: Pessimistic Outcome: Missed

Analysts cautious — risk outweighs reward.

Experts are concerned about the stock's recent price drops and mixed analyst opinions, despite some upgrades. The current setup suggests potential downside may outweigh the upside.

Context analyzed before publication

Summary
Analysts cautious — risk outweighs reward.
Reasoning
Experts are concerned about the stock's recent price drops and mixed analyst opinions, despite some upgrades. The current setup suggests a pessimistic scenario may outweigh the optimistic one.
Playbook
Given the current negative momentum and analyst target cuts, the scenario suggests waiting for a clearer positive context before considering new positions.
Trend
Outlook deteriorating over past three sessions.

Analysts

Drivers

  • Analysts Negative

    While some analysts have upgraded the stock, others have lowered their price targets. The net effect of these changes suggests caution, as target reductions are more impactful than upgrades.

Evidence

Analyst consensus
Buy
Consensus average (1-5)
2.1
Analysts covering the stock
19
Average price target
95.63
Lowest price target
79
Highest price target
105
Upside to price target
16.9%
Revenue growth
5.8%
Forward EPS
4.09
Trailing EPS
2.63
Analyst moves in the last 60 days
8
  • Strong buy: 6
  • Buy: 7
  • Hold: 7
  • Sell: 0
  • Strong sell: 0
Strong buy
6
Buy
7
Hold
7
Sell
0
Strong sell
0
  • April 21, 2026 · Rothschild& Co: Upgrades rating (Neutral → Buy)
  • April 17, 2026 · JP Morgan: Maintains rating (Overweight → Overweight)
  • April 14, 2026 · Barclays: Maintains rating (Equal-Weight → Equal-Weight)
  • April 10, 2026 · B of A Securities: Maintains rating (Buy → Buy)
  • April 8, 2026 · Wells Fargo: Maintains rating (Equal-Weight → Equal-Weight)
  • April 8, 2026 · Piper Sandler: Maintains rating (Overweight → Overweight)
  • April 7, 2026 · UBS: Maintains rating (Buy → Buy)
  • March 30, 2026 · Deutsche Bank: Upgrades rating (Hold → Buy)

News and sentiment

Drivers

  • News & sentiment Negative

    Online discussions show strong positive sentiment from individual investors, but this is not supported by market review volume, suggesting it may not reflect genuine conviction. Mixed news also adds to the uncertainty.

Evidence

Sentiment
Sentiment
Constructive
Mention volume
Low
Normalized volume
33%
News
Sources (9)
  • Rothschild & Co Upgrades Colgate-Palmolive to Buy, Raises Price Target to $100 — Benzinga
  • JP Morgan Maintains Overweight on Colgate-Palmolive, Lowers Price Target to $95 — Benzinga
  • Barclays Maintains Equal-Weight on Colgate-Palmolive, Lowers Price Target to $79 — Benzinga
  • B of A Securities Maintains Buy on Colgate-Palmolive, Lowers Price Target to $102 — Benzinga
  • Wells Fargo Maintains Equal-Weight on Colgate-Palmolive, Lowers Price Target to $92 — Benzinga
  • Piper Sandler Maintains Overweight on Colgate-Palmolive, Lowers Price Target to $92 — Benzinga
  • UBS Maintains Buy on Colgate-Palmolive, Lowers Price Target to $98 — Benzinga
  • Deutsche Bank Upgrades Colgate-Palmolive to Buy, Raises Price Target to $98 — Benzinga
  • Elon Musk's X Loses Advertiser Boycott Lawsuit As 'Teflon Elon' Legal Streak Unravels — Benzinga

Technicals

Drivers

  • Technical Negative

    The stock's recent performance has been significantly weaker than the broader market. It is currently market review closer to its support level than its resistance level, which limits the optimistic scenario.

Evidence

Average true range (ATR)
2.4%
Distance to 52-week high
-17.6%
14-day change (14d)
-4.2%
30-day change
-11.5%
30-day relative strength
-15.3%
Benchmark change
+3.8%
Nearest support
81.8
Nearest resistance
93.47
Volume accumulation ratio
0.76

Trends

Evidence

Average earnings surprise
+3.9%
  • January 30, 2026: actual EPS 0.95 vs estimate 0.91 (surprise +4.2%)
  • October 31, 2025: actual EPS 0.91 vs estimate 0.89 (surprise +2.4%)
  • August 1, 2025: actual EPS 0.92 vs estimate 0.89 (surprise +2.8%)
  • April 25, 2025: actual EPS 0.91 vs estimate 0.86 (surprise +6.1%)

Expected move

There is no implied-move data available for this event.

Reactions over its last 19 earnings

Median move
2%
75th percentile move
4.4%
90th percentile move
5.1%
Up / down moves
9 / 10
Average up move
+2.2%
Average down move
-3.0%

Monitoring and close

What Colgate-Palmolive Company reported

There is no monitoring data available for this event.

Pre-market second reading after the results

There is no second reading available for this event.

How the stock reacted

Outcome
Missed
Consolidated
+2.2%
Max favorable move (MFE)
0%
Max adverse move (MAE)
4.6%